MarketInOut Stock Screener Log In | Sign Up

Physiomics Plc

LSE • Healthcare • Biotechnology • Quote as of 10/27/2026 12:59
Physiomics Plc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization2.15 mln
Float295 mln
Earnings Date03/11/2027

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-1.44
Manipulation likely

Relative Strength

50 / 100
In line with market

Pre-Tax Margin

-73%
Severely loss-making

ROE

-130
Deeply negative

Altman Z-Score

-11.38
Deeply distressed

Business Description

Physiomics Plc is an Oxford-based company founded in 2001 that helps drug developers make better decisions through advanced computer modeling and data analysis. Using its own Virtual Tumour software, the company specializes in cancer research, predicting how tumors respond to treatment to speed up and improve the drug development process. It also works toward tailoring medical treatments to individual patients. Physiomics serves clients across the UK, US, and Europe.

Key Fundamentals

EPS-0.20
ROE-130
RPS0.00
ROIC-421
ROA-93.41
EBITDA, mln-0.68
EV / EBITDA-2.09
EV / EBIT-2.06
Revenue, mln0.94
EV / Revenue1.50

Quote Details

Last 0.4699
Change 0 (0%)
Open 0.4699
Volume 595,612
Turnover 279,878
Average Volume 1,378,600

Financial Ratios

Pre-Tax Profit Margin-73
Leverage Ratio1.50
Current Ratio2.88
Price / Book4.75
Price / Sales1.58

Financial Strength

Altman Z-Score-11.38
Piotroski F-Score 3 / 9
Beneish M-Score-1.44

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.42% 93 / 100   
1 Month -14.56% 6 / 100   
2 Months -9.2% 15 / 100   
6 Months 1.05% 44 / 100   
1 Year 4.42% 43 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog